358 related articles for article (PubMed ID: 25100124)
1. A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure.
Shen T; Lin BY; Jia JJ; Wang ZY; Wang L; Ling Q; Geng L; Yan S; Zheng SS
Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):395-401. PubMed ID: 25100124
[TBL] [Abstract][Full Text] [Related]
2. Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab.
Raut V; Mori A; Kaido T; Ogura Y; Taku I; Nagai K; Sasaki N; Endo K; Hata T; Yagi S; Egawa H; Uemoto S
Transplantation; 2012 Jan; 93(1):99-105. PubMed ID: 22094955
[TBL] [Abstract][Full Text] [Related]
3. Single-Center Experience of ABO-Incompatible Living-Donor Liver Transplantation With a New Simplified Intravenous Immunoglobulin Protocol: A Propensity Score-Matching Analysis.
Kim JD; Choi DL; Kim SG; Lee AJ
Transplant Proc; 2016 May; 48(4):1134-8. PubMed ID: 27320573
[TBL] [Abstract][Full Text] [Related]
4. Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation.
Takahashi K; Saito K; Takahara S; Fuchinoue S; Yagisawa T; Aikawa A; Watarai Y; Yoshimura N; Tanabe K; Morozumi K; Shimazu M;
Clin Exp Nephrol; 2017 Aug; 21(4):705-713. PubMed ID: 27534951
[TBL] [Abstract][Full Text] [Related]
5. Section 15. A desensitizing protocol without local graft infusion therapy and splenectomy is a safe and effective method in ABO-incompatible adult LDLT.
Song GW; Lee SG; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Jung DH; Park GC; Park HW; Park YH; Kang SH; Jung BH
Transplantation; 2014 Apr; 97 Suppl 8():S59-66. PubMed ID: 24849837
[TBL] [Abstract][Full Text] [Related]
6. A simplified protocol using rituximab and immunoglobulin for ABO-incompatible low-titre living donor liver transplantation.
Kim SH; Lee EC; Shim JR; Park SJ
Liver Int; 2018 May; 38(5):932-939. PubMed ID: 29053910
[TBL] [Abstract][Full Text] [Related]
7. ABO-incompatible living donor liver transplantation without graft local infusion and splenectomy.
Lee SD; Kim SH; Kong SY; Kim YK; Lee SA; Park SJ
HPB (Oxford); 2014 Sep; 16(9):807-13. PubMed ID: 24467804
[TBL] [Abstract][Full Text] [Related]
8. ABO-Incompatible Living Donor Liver Transplantation With a Simplified Desensitization and Immunosuppression Protocol: A Single-Center Retrospective Study.
Lee TB; Ko HJ; Shim JR; Choi BH; Ryu JH; Yang K
Exp Clin Transplant; 2021 Jul; 19(7):676-685. PubMed ID: 34325624
[TBL] [Abstract][Full Text] [Related]
9. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: a new protocol in ABO incompatible living donor liver transplantation.
Ikegami T; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Harada N; Iguchi T; Hashimoto N; Maehara Y
Transplantation; 2009 Aug; 88(3):303-7. PubMed ID: 19667930
[TBL] [Abstract][Full Text] [Related]
10. ABO-incompatible liver transplantation in acute liver failure: a single Portuguese center study.
Mendes M; Ferreira AC; Ferreira A; Remédio F; Aires I; Cordeiro A; Mascarenhas A; Martins A; Pereira P; Gloria H; Perdigoto R; Veloso J; Ferreira P; Oliveira J; Silva M; Barroso E; Nolasco F
Transplant Proc; 2013 Apr; 45(3):1110-5. PubMed ID: 23622639
[TBL] [Abstract][Full Text] [Related]
11. Discrepancy of B cell frequency between periphery and spleen after rituximab treatment in ABO-incompatible liver transplantation.
Iso Y; Sawada T; Kita J; Shiraki T; Sakuraoka Y; Kato M; Shimoda M; Kubota K
Hepatogastroenterology; 2013 Oct; 60(127):1624-6. PubMed ID: 24634932
[TBL] [Abstract][Full Text] [Related]
12. Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation.
Ashimine S; Watarai Y; Yamamoto T; Hiramitsu T; Tsujita M; Nanmoku K; Goto N; Takeda A; Katayama A; Uchida K; Kobayashi T
Kidney Int; 2014 Feb; 85(2):425-30. PubMed ID: 23945498
[TBL] [Abstract][Full Text] [Related]
13. Results of ABO-incompatible liver transplantation using a simplified protocol at a single institution.
Lee J; Lee JG; Lee JJ; Kim MS; Ju MK; Choi GH; Choi JS; Kim SI; Joo DJ
Transplant Proc; 2015 Apr; 47(3):723-6. PubMed ID: 25891718
[TBL] [Abstract][Full Text] [Related]
14. Pinpoint targeted immunosuppression: anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy.
Saito K; Nakagawa Y; Suwa M; Kumagai N; Tanikawa T; Nishiyama T; Ueno M; Gejyo F; Nishi S; Takahashi K
Xenotransplantation; 2006 Mar; 13(2):111-7. PubMed ID: 16623803
[TBL] [Abstract][Full Text] [Related]
15. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
[TBL] [Abstract][Full Text] [Related]
16. A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation.
Lee EC; Kim SH; Shim JR; Park SJ
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):119-125. PubMed ID: 29576278
[TBL] [Abstract][Full Text] [Related]
17. Association between response to rituximab and antibody-mediated rejection in ABO-incompatible living kidney transplantation.
Maenosono R; Unagami K; Kakuta Y; Furusawa M; Okumi M; Azuma H; Ishida H; Tanabe K
Int J Urol; 2019 Dec; 26(12):1114-1120. PubMed ID: 31522467
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of rituximab dosage for ABO-incompatible living-donor kidney transplantation.
Nakao T; Ushigome H; Kawai K; Nakamura T; Harada S; Koshino K; Suzuki T; Ito T; Nobori S; Yoshimura N
Transplant Proc; 2015 Apr; 47(3):644-8. PubMed ID: 25891703
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation.
Sugiyama K; Hyodo Y; Aikawa A
Int J Urol; 2015 Oct; 22(10):931-6. PubMed ID: 26108258
[TBL] [Abstract][Full Text] [Related]
20. Strategic breakthrough in adult ABO-incompatible living donor liver transplantation: preliminary results of consecutive seven cases.
Soejima Y; Muto J; Matono R; Ninomiya M; Ikeda T; Yoshizumi T; Uchiyama H; Ikegami T; Shirabe K; Maehara Y
Clin Transplant; 2013; 27(2):227-31. PubMed ID: 23293980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
